Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 PharmGKB summary: very important pharmacogene information for RYR1.

× No keyword cloud information.

78 in total

1. Identification of the Arg1086His mutation in the alpha subunit of the voltage-dependent calcium channel (CACNA1S) in a North American family with malignant hyperthermia.

Authors: S L Stewart; K Hogan; H Rosenberg; J E Fletcher
Journal: Clin Genet Date: 2001-03 Impact factor: 4.438

Review 2. Caffeine and excitation-contraction coupling in skeletal muscle: a stimulating story.

Authors: A Herrmann-Frank; H C Lüttgau; D G Stephenson
Journal: J Muscle Res Cell Motil Date: 1999-02 Impact factor: 2.698

Review 3. Skeletal muscle excitation-contraction coupling: who are the dancing partners?

Authors: Robyn T Rebbeck; Yamuna Karunasekara; Philip G Board; Nicole A Beard; Marco G Casarotto; Angela F Dulhunty
Journal: Int J Biochem Cell Biol Date: 2013-12-24 Impact factor: 5.085

4. Malignant hyperthermia testing in probands without adverse anesthetic reaction.

Authors: Matthew A Timmins; Henry Rosenberg; Marilyn Green Larach; Carly Sterling; Natalia Kraeva; Sheila Riazi
Journal: Anesthesiology Date: 2015-09 Impact factor: 7.892

5. Ca2+ uptake and Ca2+ release by skeletal muscle sarcoplasmic reticulum: differing sensitivity to inhalational anesthetics.

Authors: T E Nelson; T Sweo
Journal: Anesthesiology Date: 1988-10 Impact factor: 7.892

Review 6. Individualized risk for statin-induced myopathy: current knowledge, emerging challenges and potential solutions.

Authors: QiPing Feng; Russell A Wilke; Tesfaye M Baye
Journal: Pharmacogenomics Date: 2012-04 Impact factor: 2.533

7. Enhanced response to caffeine and 4-chloro-m-cresol in malignant hyperthermia-susceptible muscle is related in part to chronically elevated resting [Ca2+]i.

Authors: José R López; Nancy Linares; Isaac N Pessah; Paul D Allen
Journal: Am J Physiol Cell Physiol Date: 2004-11-10 Impact factor: 4.249

8. Excitation-contraction uncoupling and muscular degeneration in mice lacking functional skeletal muscle ryanodine-receptor gene.

Authors: H Takeshima; M Iino; H Takekura; M Nishi; J Kuno; O Minowa; H Takano; T Noda
Journal: Nature Date: 1994-06-16 Impact factor: 49.962

9. Halothane modulation of skeletal muscle ryanodine receptors: dependence on Ca2+, Mg2+, and ATP.

Authors: Paula L Diaz-Sylvester; Maura Porta; Julio A Copello
Journal: Am J Physiol Cell Physiol Date: 2008-02-27 Impact factor: 4.249

10. Dantrolene-induced inhibition of skeletal L-type Ca2+ current requires RyR1 expression.

Authors: R A Bannister
Journal: Biomed Res Int Date: 2012-12-05 Impact factor: 3.411

4 in total

Review 1. Germline genetic variants with implications for disease risk and therapeutic outcomes.

Authors: Amy L Pasternak; Kristen M Ward; Jasmine A Luzum; Vicki L Ellingrod; Daniel L Hertz
Journal: Physiol Genomics Date: 2017-09-08 Impact factor: 3.107

Review 2. Pharmacogenomic considerations for medications in the perioperative setting.

Authors: Ellie H Jhun; Jeffrey L Apfelbaum; David M Dickerson; Sajid Shahul; Randall Knoebel; Keith Danahey; Mark J Ratain; Peter H O'Donnell
Journal: Pharmacogenomics Date: 2019-07 Impact factor: 2.638

Review 3. Translating Pharmacogenetics and Pharmacogenomics to the Clinic: Progress in Human and Veterinary Medicine.

Authors: Deirdre P Campion; Fiona J Dowell
Journal: Front Vet Sci Date: 2019-02-11

4. Novel Variants in Individuals with RYR1-Related Congenital Myopathies: Genetic, Laboratory, and Clinical Findings.

Authors: Joshua J Todd; Muslima S Razaqyar; Jessica W Witherspoon; Tokunbor A Lawal; Ami Mankodi; Irene C Chrismer; Carolyn Allen; Mary D Meyer; Anna Kuo; Monique S Shelton; Kim Amburgey; Dmitriy Niyazov; Pierre Fequiere; Carsten G Bönnemann; James J Dowling; Katherine G Meilleur
Journal: Front Neurol Date: 2018-03-05 Impact factor: 4.003

4 in total